We analyzed the correlation between the expression of these miRNAs and clinicopathological parameters, including clinical stage, lymph node metastasis, and distant metastasis to verify the role of ALDH1(+)-associated miRNAs in ovarian cancer. Here, ALDH1A1 is linked to metastatic malignant neoplasm in the lymph nodes.